Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

September 7, 2022

Study Completion Date

September 7, 2022

Conditions
Antibiotic Side EffectAntibiotic-associated DiarrheaAntibiotic-induced DysbiosisAntibiotic-induced Epithelial Barrier Disintegrity
Interventions
OTHER

Ciprofloxacin + Metronidazole

Participants will be instructed to take 1 capsule of Ciprofloxacin (500mg) twice daily for 7 days and 1 capsule of Metronidazole (500mg) thrice daily for 7 days. Antibiotics should be taken at least 2 hours before or 6 hours after mineral supplements containing magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc.

OTHER

SH-DS01

SH-DS01 is a rationally defined microbial consortia consisting of 24 strains across 12 species, with polyphenolic and phenolic prebiotic bioactive compounds. Participants will be instructed to take 2 capsules daily for the duration of the trial.

OTHER

Placebo

Placebo capsules for SH-DS01 will contain rice flour matched for color and texture in an identical outer capsule shell. Participants will be instructed to take 2 capsules daily for the duration of the trial.

Trial Locations (1)

N6A 5R8

KGK Science, London

All Listed Sponsors
lead

Seed Health

INDUSTRY

NCT04171466 - Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy | Biotech Hunter | Biotech Hunter